In obesity, lipolysis is often dysregulated due to chronic IR and increased levels of inflammatory cytokines (such as TNF-α and IL-6), which impair insulin’s antilipolytic action (Sancar et al., 2024 [162]). This evidence concerns the gene IL6 and obesity disorder.